10x Genomics unveiled its Atera spatial platform at AACR 2026, positioning the instrument for whole-transcriptome spatial biology at scale. Company leadership said Atera addresses measurement trade-offs seen in existing spatial tools, with the platform designed to expand throughput and plex relative to 10x’s Xenium system. According to the report, Atera is priced at $495,000 and is scheduled for availability in the second half of the year. The coverage cites performance metrics including higher throughput and increased plex capacity for targeted assays and whole transcriptome workflows. If broadly adopted, Atera could accelerate tissue-context gene expression studies for oncology biomarker research and translational studies where spatial resolution and sample throughput remain limiting factors.